842 related articles for article (PubMed ID: 15790434)
21. Utility of p16 Immunohistochemistry in Evaluating Negative Cervical Biopsies Following High-risk Pap Test Results.
Shain AF; Kwok S; Folkins AK; Kong CS
Am J Surg Pathol; 2018 Jan; 42(1):69-75. PubMed ID: 29112019
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of p16 immunostaining to predict high-grade cervical intraepithelial neoplasia in women with Pap results of atypical squamous cells of undetermined significance.
Guo M; Warriage I; Mutyala B; Patel S; Lin E; Gong Y; Sneige N
Diagn Cytopathol; 2011 Jul; 39(7):482-8. PubMed ID: 20607682
[TBL] [Abstract][Full Text] [Related]
23. Correlation of High-Risk HPV Genotypes with Pap Test Findings: A Retrospective Study in Eastern Province, Saudi Arabia.
Kussaibi H; Al Dossary R; Ahmed A; Muammar A; Aljohani R
Acta Cytol; 2021; 65(1):48-55. PubMed ID: 32784299
[TBL] [Abstract][Full Text] [Related]
24. Expression of p16INK4A in Pap smears containing atypical glandular cells from the uterine cervix.
Nieh S; Chen SF; Chu TY; Lai HC; Fu E
Acta Cytol; 2004; 48(2):173-80. PubMed ID: 15098536
[TBL] [Abstract][Full Text] [Related]
25. p16/Ki-67 dual staining has a better accuracy than human papillomavirus (HPV) testing in women with abnormal cytology under 30 years old.
Pirtea L; Secosan C; Margan M; Moleriu L; Balint O; Grigoras D; Sas I; Horhat F; Jianu A; Ilina R
Bosn J Basic Med Sci; 2019 Nov; 19(4):336-341. PubMed ID: 29924960
[TBL] [Abstract][Full Text] [Related]
26. Immunocytochemical expression of p16INK4A and Ki-67 in cytologically negative and equivocal pap smears positive for oncogenic human papillomavirus.
Longatto Filho A; Utagawa ML; Shirata NK; Pereira SM; Namiyama GM; Kanamura CT; Santos Gda C; de Oliveira MA; Wakamatsu A; Nonogaki S; Roteli-Martins C; di Loreto C; Mattosinho de Castro Ferraz Mda G; Maeda MY; Alves VA; Syrjänen K
Int J Gynecol Pathol; 2005 Apr; 24(2):118-24. PubMed ID: 15782067
[TBL] [Abstract][Full Text] [Related]
27. P16(INK4a) immunocytochemistry in liquid-based cytology samples in equivocal Pap smears: added value in management of women with equivocal Pap smear.
Monsonego J; Pollini G; Evrard MJ; Sednaoui P; Monfort L; Quinzat D; Dachez R; Syrjänen K
Acta Cytol; 2007; 51(5):755-66. PubMed ID: 17910346
[TBL] [Abstract][Full Text] [Related]
28. P16/Ki-67 Dual Staining in Positive Human Papillomavirus DNA Testing for Predictive Diagnosis of Abnormal Cervical Lesions in Northeastern Thai Women.
Aromseree S; Wongjumpa W; Ekalaksananan T; Temtanakitpaisan A; Kleebkaow P; Srisathaporn S; Tongchai P; Pientong C
Asian Pac J Cancer Prev; 2022 Oct; 23(10):3405-3411. PubMed ID: 36308365
[TBL] [Abstract][Full Text] [Related]
29. Correlation of Pap smear, cervical biopsy, and clinical follow-up with an HPV typing microarray system.
Nuovo GJ; Bartholomew D; Jung WW; Han IK; Um T; Grabarz DF; Lee DJ; McCabe RT
Diagn Mol Pathol; 2008 Jun; 17(2):107-11. PubMed ID: 18382353
[TBL] [Abstract][Full Text] [Related]
30. Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results.
Manos MM; Kinney WK; Hurley LB; Sherman ME; Shieh-Ngai J; Kurman RJ; Ransley JE; Fetterman BJ; Hartinger JS; McIntosh KM; Pawlick GF; Hiatt RA
JAMA; 1999 May; 281(17):1605-10. PubMed ID: 10235153
[TBL] [Abstract][Full Text] [Related]
31. Contribution of human papillomavirus testing by hybrid capture in the triage of women with repeated abnormal pap smears before colposcopy referral.
Fait G; Kupferminc MJ; Daniel Y; Geva E; Ron IG; Lessing JB; Bar-Am A
Gynecol Oncol; 2000 Nov; 79(2):177-80. PubMed ID: 11063640
[TBL] [Abstract][Full Text] [Related]
32. Is the human papillomavirus test in combination with the Papanicolaou test useful for management of patients with diagnoses of atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesions?
Lee NW; Kim D; Park JT; Kim A
Arch Pathol Lab Med; 2001 Nov; 125(11):1453-7. PubMed ID: 11698001
[TBL] [Abstract][Full Text] [Related]
33. Sensitivity and specificity values of high-risk HPV DNA, p16/ki-67 and HPV mRNA in young women with atypical squamous cells of undetermined significance (ASCUS) or low-grade squamous intraepithelial lesion (LSIL).
Frega A; Pavone M; Sesti F; Leone C; Bianchi P; Cozza G; Colombrino C; Lukic A; Marziani R; De Sanctis L; Delli Carpini G; Caserta D; Ciavattini A
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10672-10677. PubMed ID: 31858534
[TBL] [Abstract][Full Text] [Related]
34. The expression of p16 (INK4a) and Ki-67 in relation to high-risk human papilloma viral load and residual disease after conization with positive margins.
Song SH; Park HM; Eom DW; Lee JK; Lee NW; Kim AR; Hur JY; Lee KW; Park YK; Saw HS
Int J Gynecol Cancer; 2007; 17(4):858-67. PubMed ID: 17367326
[TBL] [Abstract][Full Text] [Related]
35. Human papillomavirus genotyping and p16INK4a expression in cervical intraepithelial neoplasia of adolescents.
Hu L; Guo M; He Z; Thornton J; McDaniel LS; Hughson MD
Mod Pathol; 2005 Feb; 18(2):267-73. PubMed ID: 15492761
[TBL] [Abstract][Full Text] [Related]
36. Persistence and load of high-risk HPV are predictors for development of high-grade cervical lesions: a longitudinal French cohort study.
Dalstein V; Riethmuller D; Prétet JL; Le Bail Carval K; Sautière JL; Carbillet JP; Kantelip B; Schaal JP; Mougin C
Int J Cancer; 2003 Sep; 106(3):396-403. PubMed ID: 12845680
[TBL] [Abstract][Full Text] [Related]
37. Immunohistochemical assessment of p16, COX-2 and EGFR in HPV-positive cervical squamous intraepithelial lesions.
Balan R; Simion N; Giuşcă SE; Grigoraş A; Gheucă-Solovăstru L; Gheorghiţă V; Amălinei C; Căruntu ID
Rom J Morphol Embryol; 2011; 52(4):1187-94. PubMed ID: 22203921
[TBL] [Abstract][Full Text] [Related]
38. [Results of pap smears and immunocytochemical detection of the p16 and Ki67 proteins in women with cervical intraepithelial neoplasia and cervical cancer].
Rokita W; Skawiński D; Zmelonek-Znamirowska A; Kedzia W; Karowicz-Bilińska A; Spaczyński R; Spaczyński M
Ginekol Pol; 2012 Nov; 83(11):822-6. PubMed ID: 23379189
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of p16INK4a as a diagnostic tool in the triage of Pap smears demonstrating atypical squamous cells of undetermined significance.
Duncan L; Jacob S; Hubbard E
Cancer; 2008 Feb; 114(1):34-48. PubMed ID: 18186493
[TBL] [Abstract][Full Text] [Related]
40. p16INK4A immunohistochemistry is superior to HPV in situ hybridization for the detection of high-risk HPV in atypical squamous metaplasia.
Kong CS; Balzer BL; Troxell ML; Patterson BK; Longacre TA
Am J Surg Pathol; 2007 Jan; 31(1):33-43. PubMed ID: 17197917
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]